Nuritas
Company

Last deal

$45M
Local Amount - EUR 39.3M

Amount

Series B

Stage

11.11.2021

Date

8

all rounds

$105.7M

Total amount

General

About Company
Nuritas uses AI and genomics to discover natural bioactive peptides with health benefits.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2014

Number of employees

Company Type

For Profit

Last funding type

Series B

IPO status

Private

Description

The company's biotechnology platform combines AI and genomics to extract peptides from food sources, making the food system more sustainable by replacing unwanted ingredients with more natural and sustainable ones. Nuritas' unique Nuritas MagnifierNπΦ platform identifies, unlocks, clinically tests, and patents peptides, turning them into powerful and precise ingredients that elevate natural efficacy. The company aims to empower people to live healthier lives by making everyday products healthier, safer, greener, and more efficacious, translating nature's wisdom into innovation to change the lives of billions.
Contacts

Phone number

Social url